MedTrace Logo

A Randomized Controlled Clinical Trial to Evaluate Safety and Effectiveness of CAF + Mucograft® Compared to CAF Alone in Patients With Gingival Recessions

NCT00902876 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2019-02-08

No results posted yet for this study

Summary

The purpose of this multi-center study is to determine the efficacy and safety of Mucograft® in combination with the coronally advanced flap (CAF) for the treatment of gingival recessions. It is assumed that the CAF combined with Mucograft® will result in improved outcome in terms percentage of root coverage and soft tissue thickness in comparison to CAF alone (control).

Conditions

  • Gingival Recession

Interventions

DEVICE

Mucograft

Collagen Matrix for soft tissue regeneration

PROCEDURE

Coronally advanced flap (CAF)

Sponsors & Collaborators

  • Geistlich Pharma AG

    lead INDUSTRY

Principal Investigators

  • Mariano Sanz, Prof. · Department of Periodontology, University Complutense Madrid, Spain

  • Soren Jepsen, Prof. · Department of Periodontology, University of Bonn, Germany

  • Jan Wennström, Prof. · Department of Periodontology, University of Gothenburg, Sweden

  • Giovanni Zucchelli, Prof. · Department of Periodontology, University of Bologna, Italy

  • Lorenz Uebersax, Dr. · Geistlich Pharma AG, Wolhusen, Switzerland

  • Bernd Heinz, Dr · Private practice Hamburg, Germany

  • Massimo DeSanctis, Prof. · Private Practice Firenze

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-07-31
Completion
2012-01-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00902876 on ClinicalTrials.gov